Infliximab 120mg/1ml solution for injection pre-filled disposable devices
NHS hospitals in England used £119,417,980 of indicative cost of Infliximab 120mg/1ml solution for injection pre-filled disposable devices in the 12 months to July 2026, about 0.5% of all hospital medicines spend. That is up 42.4% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Infliximab 120mg/1ml solution for injection pre-filled disposable devices: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to July 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Infliximab 120mg/1ml solution for injection pre-filled disposable devices most
By indicative cost over the 12 months to July 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Barts Health Nhs Trust | £6,434,193 |
| Leeds Teaching Hpls Nhs Trust | £4,130,845 |
| Sheffield Teaching Hospitals Nhs Trust | £3,703,334 |
| Portsmouth Hospitals Nhs Trust | £3,591,169 |
| Cambridge Univ Hosp Nhs Foundation Trust | £3,472,961 |
| Frimley Health Nhs Foundation Trust | £3,269,403 |
| Luton & Dunstable Hospital Trust | £3,068,865 |
| Hull And East Yorkshire Hpls Nhs Trust | £2,949,525 |
| East Kent Hospitals University Nhs Ft | £2,829,051 |
| Chelsea & Westminster Hospital Nhs Ft | £2,473,295 |
The primary-care picture
Infliximab is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Infliximab medicine page.